This paper: (i) describes the worldwide prevalence of erectile dysfunction (ED); (ii) presents agespeci®c incidence rates for ED in the US; (iii) summarizes some key epidemiologic correlates of ED in the general population; and (iv) considers the possibility that ED may be a biobehavioral marker (sentinel event) of subsequent cardiovascular disease in men. Clinical, anthropometric, life style and hormonal data are presented from the milestone Massachusetts Male Aging Study (MMAS), a large (over 1000) prospective cohort of randomly sampled community-dwelling, normally aging men. Newly updated population prevalence and (more importantly) age-speci®c incidence rates are reported. We also estimate the likely magnitude of ED that will accompany the worldwide globalization of aging. Key correlates (predictors) of incident ED, especially vasculogenic in¯uences, are identi®ed and discussed. In conclusion, ED is a common biobehavioral phenomenon and there are strong physiological and epidemiological reasons for considering it a major marker (or predictor) of subsequent cardiovascular disease in men.
Introduction
There was very little reliable information on erectile dysfunction (ED) available until the very end of the twentieth century. 1 Pioneering contributions during the 1950s were not extended into later decades and half-century-old ®ndings had little relevance to very different subsequent cohorts. That situation has changed dramatically Ð more has been learned about ED (a medical condition formerly termed impotence') during the past decade than was known during the rest of the twentieth century combined. Prior to about 1985, most information on ED was based on clinical impressions and studies of convenience samples of atypical patients.
The Massachusetts Male Aging Study (MMAS) was the ®rst major epidemiologic investigation of ED 2, 3 and it is the largest population-based study to date with information on the prevalence, incidence and etiology of ED. The overall research design of the MMAS is summarized in Figure 1 . The MMAS is a random-sample prospective study of health and aging in middle-aged men, addressing speci®c conditions of importance to older men (prostate cancer (PCa), hormone status, and erectile function) in the context of comprehensive information on physiology, behavior, illness, medication, anthropometrics, sexual activity, psychology and lifestyle. 4 It is the only large random sample study to provide longitudinal data regarding the epidemiology of ED and other aspects of sexual function in men over the age of 60. The MMAS baseline study (1987 ± 1989) established a cohort of 1709 men aged 40 ± 70, of whom 1156 were re-interviewed in 1995 ± 1997. The study has provided important new cross-sectional and longitudinal information regarding changes in hormone status and sexual function with respect to aging, the relation of these changes to ED and prostate cancer, and preliminary evidence for a relation between ED and cardiovascular disease.
Prevalence and worldwide burden
The prevalence of minimal, moderate and complete ED from the baseline (T1) MMAS (1987 MMAS ( ± 1989 ) is summarized in Figure 2 . It should be noted that these estimates improve upon and re®ne our earlier published estimates, 2 mainly as a result of a better method (a new discriminant function) for estimating ED in a population-based epidemiological study. 5 Our new approach is less susceptible to selection bias, results in less missing data and has greater construct validity than our earlier widely accepted method. 2 The prevalence and degree of ED (minimal, moderate and complete) clearly increases with age. While 8% of men in their forties report either moderate or complete ED, this approaches 40% in men aged 60 ± 69 y. In short, men between the ages of 60 and 69 y experience more than four times the level of moderate or complete ED compared to their 40 ± 49-y-old counterparts.
Using recent MMAS estimates, Figure 3 shows the likely worldwide (age-adjusted) prevalence of ED between 1995 and 2025 (employing the most conservative, ie lowest, United Nations population projections). 6 The worldwide prevalence of ED will probably increase from 152 million men in 1995 to 322 million men with ED in 2025, representing an increase of 170 million. 7 Much of this increase will occur in the developing world and is associated with the aging of the world's population. Other related factors (secular increases in weight, dietary changes, smoking behavior and an emerging diabetes pandemic) are also contributing to the increase.
The MMAS has provided the ®rst incidence rates for ED (Table 1) . Incidence rates, which comprise new cases of a condition, or a transition from a nondiseased to a diseased state, obviously require prospective data for their calculation. Prior to the MMAS, the only published estimate of the incidence of ED was from a convenience sample of 3250 men aged 26 ± 83 y visiting a preventive medicine clinic in Texas between 1987 and 1991. 8 Johannes et al 9 has recently reported age-category speci®c incidence rates for ED and shows how they differ by sociodemographic status (education, income) and also health status.
Improving the epidemiological knowledge of ED: from observation to experimentation Once reliable incidence rates were established, it was possible to relate the presence of various chronic disease conditions (eg, heart disease, diabetes, hypertension and depression) to the development of new cases of ED. Various risk factors and lifestyles have been linked to the development of chronic diseases. For example, elevated cholesterol, smoking, lack of physical activity and hypertension are thought to be precursors of chronic heart disease (CHD) 13 and this same report also suggested a strong relationship between ED and cardiovascular disease. It was possible with the MMAS to determine whether these risk behaviors (which are related to major diseases) are also linked to the development of ED, independent of the chronic diseases for which they are precursors. This linkage marked a distinct step to the right in Figure 4 .
Elsewhere, we looked at the relationship of both active and passive smoking to the development of ED. The adjusted rate of incident ED was signi®-cantly higher in cigarette smokers (24%) than in nonsmokers (14%), with an adjusted odds ratio (OR) 1.97 and 95% con®dence interval (CI) of 1.07 ± 3.63. Passive exposure to cigarette smoke (if present both at home and at work) doubled the odds of incident ED (adjusted OR 2.07, 95% CI 1.04 ± 4.13). Cigar smoking was also strongly predictive of incident ED, with adjusted OR 2.45, 95% CI 1.9 ± 5.50. Former smokers were no more likely than nonsmokers to incur ED. These results are therefore strongly suggestive that passive smoking has the same effect on ED as active smoking. Among smokers, each increase in passive exposure increased the likelihood of incident ED. Cigar smokers had an equivalent increase in incident of ED (OR 2.45). It is noteworthy that all three forms of smoking (cigarettes, cigars and passive exposure) had equivalent independent effects on ED.
Weight is a strong independent behavioral predictor of ED. The adjusted rate of incident ED in men who were overweight (BMI b 30.0 kgam 2 ) at baseline was 22%, signi®cantly higher than those who were not overweight (12%), with adjusted OR 1.96,95% CI 1.17 ± 3.28.
While these new results represent a desirable move from cross-sectional to prospective analyses of cohort data, they still remain observational. The next step, representing a type of`quasi-experiment', was to see if changes in the risk factors that are known to be associated with ED also result in changes in incident ED. Using MMAS data, Derby and her colleagues 14 recently examined the extent to which changes in smoking, heaving drinking, sedentary lifestyle and obesity are associated with incident ED. Only physical activity (an increase from the ®rst time point (T1) to the second time point (T2)) seemed to be bene®cial, ie, those becoming more active over time seemed to have less ED, compared with those who did not change their activity levels.
Measuring ED in epidemiologic ®eld studies
Several well-known questionnaires are available for the measurement of ED. 15, 16 These instruments were developed in clinical settings, mainly for self-selected atypical populations seeking treatment for ED: they have limited use in ®eld studies with population-based samples (not patients). Major limitations of these questionnaires are: (a) they are sometimes lengthy and increase respondent burden (with multiple detailed queries on sensitive topics); (b) if items are omitted or skipped (common in selfadministered questionnaires) it is often dif®cult to calculate an overall score (resulting in missing data); (c) wordy questionnaires present dif®culties for poorly educated respondents and increase translational misunderstandings when used in cross-cultural studies. There is a need for a simple appropriate method for validly measuring degrees ED in population-based epidemiologic studies. Asking one single question has been shown to provide useful information in many other areas of health care. We developed such a question for population studies of ED and have carefully assessed its metric properties against the two established indices previously developed and validated in clinical settings. 17 It should be noted that the MMAS single question approach may be inappropriate for clinical studies, which require instruments that are sensitive enough to detect changes with medical and surgical treatments, or which must be speci®c enough to optimize case ®ndings where screening is followed by clinical evaluations. A single, direct question approach provides a practical means of assessing ED in population-based studies. With further development it should be possible to include a single question concerning ED in large national health studies (eg, NHANES) to provide estimates of ED for selected population groups and geographic regions.
Health services research and ED
Very little health services research has focused speci®cally on ED. The willingness of older men to: (a) actually seek medical care; and (b) receive appropriate effective treatment once the health system has been accessed, are now important public health issues, especially with the availability of apparently effective, well-tolerated user-friendly oral preparations. We have recently considered some of the health services research and policy implications for many countries of the availability of new treatments for ED. 6 While the MMAS could not include questions concerning health care utilization for ED, some new data are available for the United States from a national survey sample recently conducted for the American Association of Retired Persons (AARP, 1999). 18 The results are summarized in Figure 5 and show that only about 10% of men report seeking or receiving treatment for`sexual problems', and only half of these (5% of all US males b 45 y of age) have ever tried or are using sildena®l (Viagra TM ).
Summary
Some results from the largest population-based longitudinal study of male health and aging (the ongoing MMAS) are presented. Thus far, the information gathered provides the following important information about ED in our society:
(i) ED is a prevalent medical condition; (ii) it has behavioral precursors that are amenable to change; (iii) it has serious implications for quality of life; (iv) despite the availability of new pharmacologic interventions, the vast majority of aging men (even those reporting complete or moderate ED) do not seek medical care for the condition.
